Clinical trial
Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and…
NCT00007527 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00007527 |
|---|---|
| Title | Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based Practice |
| Official title | A Multicenter Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH Reckitt and Colman |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Opiate Dependence |
| Intervention type | Drug |
| Interventions | naloxone, buprenorphine |
| Enrollment | 600 |
| Start date | Aug 1, 1999 |
| Completion | Jan 1, 2002 |
| First posted | Jan 1, 2001 |
| Last update posted | Jan 21, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: